Arjo ABFRA:A39 -0.28%72 Net Margin % is 4.00% as of Mar. 2026, which is 10% below its 10-year median of 4.45. GuruFocus rates FRA:A39 with a GF Score™ of 72/100 and a GF Value™ of €3.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, Arjo AB ranks better than 65.55% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Arjo AB's Net Income for the
three
months ended in Mar. 2026 was €10.0 Mil. Arjo AB's Revenue for the
three
months ended in Mar. 2026 was €250.5 Mil. Therefore, Arjo AB's net margin for the quarter that ended in Mar. 2026 was 4.00%.
The historical rank and industry rank for Arjo AB's Net Margin % or its related term are showing as below:
FRA:A39'
s Net Margin % Range Over the Past 10 Years
Min: 1.53 Med: 4.45 Max: 8.18
Current: 3.24
FRA:A39's Net Margin % is ranked better than 65.55% of 119
companies
in the Medical Distribution industry
Industry Median: 1.53
vs FRA:A39: 3.24
Arjo AB (FRA:A39) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Arjo AB Net Margin % Related Terms
Arjo AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Arjo AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arjo AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Arjo AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB (FRA:A39) has a Net Margin % of 4.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Arjo AB and its competitors. This is 10% below median its historical median of 4.45. Over the past decade, Arjo AB's Net Margin % has ranged from 1.53 to 8.18. According to the industry distribution chart, Arjo AB ranks #41 out of 119 companies in the Medical Distribution industry, placing it in the top 34.5%.
Is Arjo AB's Net Margin % too high?
Arjo AB's current Net Margin % of 4.00% is 10% below median its 10-year median of 4.45. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 8.18. The Medical Distribution industry median Net Margin % is 1.53. Arjo AB's value of 4.00% is 161.4% above this industry median. Based on the distribution chart, Arjo AB ranks #41 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Arjo AB has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #41 out of 119 companies for Net Margin %. This puts Arjo AB in the upper half of its industry. The industry median Net Margin % is 1.53. Arjo AB's value of 4.00% is 161.4% above this benchmark. Historically, Arjo AB's own Net Margin % has ranged from 1.53 to 8.18 over the past decade. While the company's 10-year median is 4.45 vs. the industry median of 1.53, Arjo AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.53, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arjo AB's current Net Margin % of 4.00% is 161.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Arjo AB and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current Net Margin % is 4.00%, which is 10% below median its own 10-year median of 4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.24, compared to a current price of €2.16 — trading 33.4% below its estimated fair value. The current Net Margin % is 4.00%, which is 10% below median its 10-year median of 4.45 and 161.4% above the Medical Distribution industry median of 1.53. Arjo AB's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current Net Margin % is 4.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (FRA:A39) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of €2.16 is trading 33.4% below its estimated GF Value™ of €3.24.
GuruFocus considers Arjo AB to be Significantly Undervalued.
Key valuation signals for FRA:A39:
Net Margin %: 4.00% (10% below median its 10-year median of 4.45)
GF Value™: €3.24 vs. price of €2.16 (33.4% below fair value)
Industry Position: 161.4% above the Medical Distribution median (#41 of 119)
No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
72GF Score
Get the complete analysis for FRA:A39
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A39 has been successfully added to your 
